{"id":55347,"date":"2026-02-24T11:41:49","date_gmt":"2026-02-24T11:41:49","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/primary-immunodeficiency-therapeutics-market-mordor\/"},"modified":"2026-10-02T01:00:48","modified_gmt":"2026-10-01T16:00:48","slug":"primary-immunodeficiency-therapeutics-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/primary-immunodeficiency-therapeutics-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2025-2030\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/primary-immunodeficiency-therapeutics-market_1663764459573_Primary_Immunodeficiency_therapuetics_market_-_major_players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/primary-immunodeficiency-therapeutics-market-size-image-1735459292624.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \uc5ed\ud559<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc720\uc804\uc790 \uce58\ub8cc\uc758 \uae30\uc220 \ubc1c\uc804<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uce58\ub8cc\ubc95\uc758 \ub192\uc740 \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.2 \uce58\ub8cc\uc640 \uad00\ub828\ub41c \ubd80\uc791\uc6a9<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \ud3ec\ud130\uc758 5\uac00\uc9c0 \ud798 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.4.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.2 \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.4 \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uc138\ubd84\ud654 (\uac00\uce58 \uae30\uc900 \uc2dc\uc7a5 \uaddc\ubaa8 &#8211; \ubc31\ub9cc USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc9c8\ubcd1 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ud56d\uccb4 \uacb0\ud54d<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc138\ud3ec\uc131 \uba74\uc5ed\uacb0\ud54d<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc120\ucc9c\uc131 \uba74\uc5ed \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.1.4 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc81c\ud488 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uba74\uc5ed\uae00\ub85c\ubd88\ub9b0 \ub300\uccb4 \uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc904\uae30\uc138\ud3ec\/\uace8\uc218 \uc774\uc2dd<\/li>\n<li class=\"toc-level-3\">5.2.3 \ud56d\uc0dd\uc81c \uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc720\uc804\uc790 \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.2.5 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.3.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.3.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.3.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.3.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.3.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.3.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.3.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.3.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.3.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.3.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.3.4.2 \ub0a8\uc544\ud504\ub9ac\uce74 \uacf5\ud654\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.3.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.3.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.3.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \ud68c\uc0ac \ud504\ub85c\ud544\n<ul>\n<li class=\"toc-level-3\">6.1.1 Baxter international Inc<\/li>\n<li class=\"toc-level-3\">6.1.2 Takeda Pharmaceutical Company Limited<\/li>\n<li class=\"toc-level-3\">6.1.3 CSL Ltd<\/li>\n<li class=\"toc-level-3\">6.1.4 Octapharma AG<\/li>\n<li class=\"toc-level-3\">6.1.5 Biotest AG<\/li>\n<li class=\"toc-level-3\">6.1.6 Kedrion Biopharma Inc<\/li>\n<li class=\"toc-level-3\">6.1.7 Bio Products Laboratory Limited<\/li>\n<li class=\"toc-level-3\">6.1.8 LFB group<\/li>\n<li class=\"toc-level-3\">6.1.9 Grifols S.A<\/li>\n<li class=\"toc-level-3\">6.1.10 Lupin Pharmaceuticals<\/li>\n<\/ul>\n<\/li>\n<li><strong>*\ubaa9\ub85d\uc740 \uc804\uccb4\uac00 \uc544\ub2d8<\/strong><\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \ub3d9\ud5a5<\/p>\n<div style=\"font-family:regular_semibold\">\uc774\uc6a9 \uac00\ub2a5 \uc5ec\ubd80\uc5d0 \ub530\ub77c \ub2ec\ub77c\uc9c8 \uc218 \uc788\uc74c<\/div>\n<div style=\"font-family:regular_semibold\">\uacbd\uc7c1 \ud658\uacbd\uc740 \ube44\uc988\ub2c8\uc2a4 \uac1c\uc694, \uc7ac\ubb34, \uc81c\ud488 \ubc0f \uc804\ub7b5, \ucd5c\uadfc \uac1c\ubc1c\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4<\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c \uc2dc\uc7a5: \uaddc\ubaa8, \uc810\uc720\uc728 \ubc0f \uc0b0\uc5c5 \ubd84\uc11d \uac1c\uc694 (2025-2030\ub144 \uc608\uce21)<\/p>\n<p># 1. \ubcf4\uace0\uc11c \uac1c\uc694 \ubc0f \uc2dc\uc7a5 \uc2a4\ub0c5\uc0f7<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uaddc\ubaa8, \uc810\uc720\uc728 \ubc0f \uc0b0\uc5c5 \ubd84\uc11d\uc744 \ub2e4\ub8e8\uba70, 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc758 \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 \uc9c8\ubcd1 \uc720\ud615\ubcc4(\ud56d\uccb4 \uacb0\ud54d, \uc138\ud3ec \uba74\uc5ed\uacb0\ud54d, \uc120\ucc9c\uc131 \uba74\uc5ed \uc9c8\ud658, \uae30\ud0c0), \uc81c\ud488 \uc720\ud615\ubcc4(\uba74\uc5ed\uae00\ub85c\ubd88\ub9b0 \ub300\uccb4 \uc694\ubc95, \uc904\uae30\uc138\ud3ec\/\uace8\uc218 \uc774\uc2dd, \ud56d\uc0dd\uc81c \uc694\ubc95, \uc720\uc804\uc790 \uce58\ub8cc, \uae30\ud0c0), \uadf8\ub9ac\uace0 \uc9c0\uc5ed\ubcc4(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ub85c \ubd84\ub958\ub429\ub2c8\ub2e4.<\/p>\n<p>Mordor Intelligence\uc758 \ubd84\uc11d\uc5d0 \ub530\ub974\uba74, \uc804 \uc138\uacc4 \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 6.10%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc5f0\uad6c \uae30\uac04\uc740 2019\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc774\uba70, \uc608\uce21 \ub370\uc774\ud130 \uae30\uac04\uc740 2025\ub144\ubd80\ud130 2030\ub144, \uacfc\uac70 \ub370\uc774\ud130 \uae30\uac04\uc740 2019\ub144\ubd80\ud130 2023\ub144\uc785\ub2c8\ub2e4. \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc740 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774\uba70, \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc740 \ubd81\ubbf8 \uc9c0\uc5ed\uc785\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \ub0ae\uc740 \ud3b8\uc785\ub2c8\ub2e4.<\/p>\n<p># 2. \uc2dc\uc7a5 \ubd84\uc11d \ubc0f \uc8fc\uc694 \ub3d9\uc778<\/p>\n<p>COVID-19 \ud32c\ub370\ubbf9\uc758 \uc601\ud5a5:<br \/>\nCOVID-19 \ud32c\ub370\ubbf9\uacfc \ud655\uc0b0 \ubc29\uc9c0\ub97c \uc704\ud55c \uc815\ubd80\uc758 \ubd09\uc1c4 \uc870\uce58\ub294 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uc601\ud5a5\uc744 \ubbf8\ucce4\uc2b5\ub2c8\ub2e4. 2022\ub144 3\uc6d4 \ubc1c\ud45c\ub41c &#8216;COVID-19 \ud32c\ub370\ubbf9\uc774 \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \ud658\uc790\uc5d0\uac8c \ubbf8\uce58\ub294 \uc601\ud5a5: \ucf54\ud638\ud2b8 \uc5f0\uad6c&#8217;\uc5d0 \ub530\ub974\uba74, \uc6d0\ubc1c\uc131 \ubc0f \uc774\ucc28\uc131 \uba74\uc5ed\uacb0\ud54d \ud658\uc790\ub4e4\uc740 \uba74\uc5ed \uccb4\uacc4\uac00 \uc2ec\uac01\ud55c \uc9c8\ubcd1\uc5d0 \ub300\ud55c \uc801\uc808\ud55c \ubc29\uc5b4 \ub2a5\ub825\uc774 \ubd80\uc871\ud558\uc5ec COVID-19 \ubc14\uc774\ub7ec\uc2a4\uc5d0 \ub354 \ub192\uc740 \uc704\ud5d8\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \ubd80\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\ucce4\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\uc778:<br \/>\n*   \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00: \ub2e4\uc591\ud55c \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658\uc758 \uc99d\uac00\uac00 \uc2dc\uc7a5 \uc131\uc7a5\uc758 \ud575\uc2ec \ub3d9\uc778\uc785\ub2c8\ub2e4. 2021\ub144 1\uc6d4 \uc5f0\uad6c\uc5d0 \ub530\ub974\uba74, \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658 \ud658\uc790\ub4e4\uc5d0\uac8c\uc11c \ub9cc\uc131 \ud3d0\uc1c4\uc131 \ud3d0\uc9c8\ud658-\ucc9c\uc2dd(51.5%), \ub958\ub9c8\ud2f0\uc2a4 \uc9c8\ud658(14%), \uacb0\ud54d\uc131 \ube48\ud608(11.8%), \uac11\uc0c1\uc120 \uae30\ub2a5 \uc800\ud558\uc99d(21.2%), \ub9bc\ud504\uc885(16.7%) \ub4f1 \ub2e4\uc591\ud55c \ub3d9\ubc18 \uc9c8\ud658\uc774 \ud1b5\uacc4\uc801\uc73c\ub85c \uc720\uc758\ubbf8\ud558\uac8c \ub354 \ud754\ud558\uac8c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4. \ub610\ud55c, 2021\ub144 7\uc6d4 \uba54\ud0c0 \ubd84\uc11d\uc5d0 \ub530\ub974\uba74 \uc544\ud1a0\ud53c \ud53c\ubd80\uc5fc \ud658\uc790\uc758 \ube44\uc5fc \uc720\ubcd1\ub960\uc740 40.5%\uc5d0 \ub2ec\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc120\ucc9c\uc131 \uba74\uc5ed \uc9c8\ud658\uc758 \uc99d\uac00\ub294 \ud6a8\uacfc\uc801\uc778 \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \ub192\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc720\uc804\uc790 \uce58\ub8cc \uae30\uc220 \ubc1c\uc804: \uc720\uc804\uc790 \uce58\ub8cc \ubd84\uc57c\uc758 \uae30\uc220 \ubc1c\uc804\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \ub610 \ub2e4\ub978 \uc8fc\uc694 \uc694\uc778\uc785\ub2c8\ub2e4.<br \/>\n*   \uae30\uc5c5 \ud65c\ub3d9 \uc99d\uac00: \uae30\uc5c5\ub4e4\uc758 \uc81c\ud488 \uac1c\ubc1c \ud65c\ub3d9 \uc99d\uac00\ub3c4 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, 2020\ub144 10\uc6d4 \uc720\ub7fd \uc704\uc6d0\ud68c\ub294 \ud65c\uc131\ud654\ub41c \ud3ec\uc2a4\ud3ec\uc774\ub178\uc2dc\ud2f0\ub4dc 3-\ud0a4\ub098\uc81c \ub378\ud0c0 \uc99d\ud6c4\uad70(APDS) \uce58\ub8cc\ub97c \uc704\ud55c \ub808\ub2c8\uc62c\ub9ac\uc2ed(leniolisib)\uc5d0 \ub300\ud574 \ud76c\uadc0\uc758\uc57d\ud488 \uc9c0\uc815\uc744 \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5 \uc800\ud574 \uc694\uc778:<br \/>\n*   \ub192\uc740 \uce58\ub8cc \ube44\uc6a9: \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c\uc758 \ub192\uc740 \ube44\uc6a9\uc740 \ud658\uc790 \uc811\uadfc\uc131\uc744 \uc81c\ud55c\ud558\uace0 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \uad00\ub828 \ubd80\uc791\uc6a9: \uce58\ub8cc\uc640 \uad00\ub828\ub41c \ubd80\uc791\uc6a9 \ub610\ud55c \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \ubd80\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8 \ubbf8\uce60 \uc218 \uc788\ub294 \uc694\uc778\uc785\ub2c8\ub2e4.<\/p>\n<p># 3. \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5: \uc720\uc804\uc790 \uce58\ub8cc \ubd80\ubb38<\/p>\n<p>\uc720\uc804\uc790 \uce58\ub8cc \ubd80\ubb38\uc740 \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00\uc640 \uc720\uc804\uc790 \uce58\ub8cc \uae30\uc220 \ubc1c\uc804 \ub355\ubd84\uc5d0 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0\uc11c \uc0c1\ub2f9\ud55c \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>*   \uc720\uc804\uc790 \uce58\ub8cc\uc758 \ubaa9\uc801: \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658(PIDs)\uc5d0 \ub300\ud55c \uc720\uc804\uc790 \uce58\ub8cc(GT)\ub294 \uc190\uc0c1\ub41c \uc720\uc804\uc790\uc758 \uae30\ub2a5\uc801 \ubcf5\uc0ac\ubcf8\uc744 \ud658\uc790\uc758 \uc870\ud608\ubaa8\uc138\ud3ec(HSCs)\uc5d0 \uc0bd\uc785\ud558\ub294 \uac83\uc744 \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4.<br \/>\n*   \uae30\uc220 \ubc1c\uc804 \ubc0f \uc548\uc804\uc131: 2021\ub144 2\uc6d4 \ubc1c\ud45c\ub41c &#8216;\uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d\uc5d0 \ub300\ud55c \uc720\uc804\uc790 \uce58\ub8cc&#8217; \ub17c\ubb38\uc5d0 \ub530\ub974\uba74, \ub80c\ud2f0\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130\uc640 \uac19\uc740 \ubcc0\ud615\ub41c \ubc14\uc774\ub7ec\uc2a4\ub294 \uc720\uc804\ub3c5\uc131 \uc5c6\uc774 \uc6b0\uc218\ud55c \uc548\uc804\uc131 \ud504\ub85c\ud30c\uc77c\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \uc801\uc6a9 \ubc94\uc704: \uc544\ub370\ub178\uc2e0 \ud0c8\uc544\ubbf8\ub178\ud6a8\uc18c \uc911\uc99d \ubcf5\ud569 \uba74\uc5ed\uacb0\ud54d(SCID), X-\uc5f0\uad00 SCID, \uc544\ub974\ud14c\ubbf8\uc2a4 SCID, \uc704\uc2a4\ucf67-\uc54c\ub4dc\ub9ac\uce58 \uc99d\ud6c4\uad70, X-\uc5f0\uad00 \ub9cc\uc131 \uc721\uc544\uc885 \uc9c8\ud658, \ubc31\ud608\uad6c \ubd80\ucc29 \uacb0\ud54d-I \ub4f1 \uc5ec\ub7ec \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658\uc774 \uc720\uc804\uc790 \uce58\ub8cc\ub85c \uc131\uacf5\uc801\uc73c\ub85c \uce58\ub8cc\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ubc1c\uc804\uc740 \uc720\uc804\uc790 \uce58\ub8cc\ub97c \uc774\uc6a9\ud55c \uce58\ub8cc\uc81c \uac1c\ubc1c\uc744 \uc99d\uac00\uc2dc\ucf1c \ud574\ub2f9 \ubd80\ubb38\uc758 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud560 \uac83\uc785\ub2c8\ub2e4.<br \/>\n*   \ube44\ud638\uc9c0\ud0a8 \ub9bc\ud504\uc885(NHL) \uc720\ubcd1\ub960 \uc99d\uac00: \ube44\ud638\uc9c0\ud0a8 \ub9bc\ud504\uc885\uc758 \uc720\ubcd1\ub960 \uc99d\uac00\ub294 \uc774 \ubd80\ubb38\uc758 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubbf8\uad6d \uc554 \ud559\ud68c(American Cancer Society)\uc758 2022\ub144 \ud1b5\uacc4\uc5d0 \ub530\ub974\uba74, 2022\ub144\uc5d0 \ubbf8\uad6d\uc5d0\uc11c \uc57d 80,470\uba85\uc774 NHL \uc9c4\ub2e8\uc744 \ubc1b\uc744 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uc720\uc804\uc790 \uce58\ub8cc \uc218\uc694\ub97c \uc99d\uac00\uc2dc\ucf1c \ud574\ub2f9 \ubd80\ubb38\uc758 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p># 4. \uc9c0\uc5ed\ubcc4 \ubd84\uc11d: \ubd81\ubbf8 \uc2dc\uc7a5<\/p>\n<p>\ubd81\ubbf8 \uc9c0\uc5ed\uc740 \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0\uc11c \uc0c1\ub2f9\ud55c \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc774\ub7ec\ud55c \ucd94\uc138\ub97c \uc720\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00, \uc720\uc804\uc790 \ubc0f \uc904\uae30\uc138\ud3ec \uce58\ub8cc \uae30\uc220 \ubc1c\uc804, \ub192\uc740 \uc758\ub8cc\ube44 \uc9c0\ucd9c \ubc0f \uc798 \uad6c\ucd95\ub41c \uc758\ub8cc \uc778\ud504\ub77c \ub4f1\uc758 \uc694\uc778\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4.<\/p>\n<p>*   \ub192\uc740 \uc758\ub8cc\ube44 \uc9c0\ucd9c: \uacbd\uc81c\ud611\ub825\uac1c\ubc1c\uae30\uad6c(OECD)\uc758 2022\ub144 \ub370\uc774\ud130\uc5d0 \ub530\ub974\uba74, 2021\ub144 \ubbf8\uad6d\uc758 \uc758\ub8cc\ube44 \uc9c0\ucd9c\uc740 GDP\uc758 17.8%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uba55\uc2dc\ucf54\ub294 2020\ub144 6.2%\ub97c \uae30\ub85d\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ub192\uc740 \uc758\ub8cc\ube44 \uc9c0\ucd9c\uc740 \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658 \uce58\ub8cc\ub97c \uc704\ud55c \ud6a8\uacfc\uc801\uc774\uace0 \uae30\uc220\uc801\uc73c\ub85c \uc9c4\ubcf4\ub41c \uce58\ub8cc\uc81c \uac1c\ubc1c\uc5d0 \ub300\ud55c \uae30\uc5c5 \ud65c\ub3d9\uc744 \uc99d\uac00\uc2dc\ucf1c \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud560 \uac83\uc785\ub2c8\ub2e4.<br \/>\n*   \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658\uc758 \ub192\uc740 \uc720\ubcd1\ub960: \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00\ub294 \uc2dc\uc7a5 \uc131\uc7a5\uc758 \uc8fc\uc694 \ub3d9\uc778\uc785\ub2c8\ub2e4.<br \/>\n    *   \uc720\uc5d4 \uc5d0\uc774\uc988(UNAIDS)\uc758 2022\ub144 \ud1b5\uacc4\uc5d0 \ub530\ub974\uba74, 2021\ub144 \ubbf8\uad6d\uc5d0\uc11c 3,840\ub9cc \uba85\uc774 HIV\uc640 \ud568\uaed8 \uc0b4\uace0 \uc788\uc5c8\uc73c\uba70, \uc57d 590\ub9cc \uba85\uc740 \uc790\uc2e0\uc758 HIV \uc0c1\ud0dc\ub97c \uc54c\uc9c0 \ubabb\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uc2dd\ud488 \uc54c\ub808\ub974\uae30 \uc5f0\uad6c \ubc0f \uad50\uc721(Food Allergy Research and Education)\uc758 2020\ub144 \ubcf4\uace0\uc11c\ub294 \ubbf8\uad6d \uac70\uc8fc\uc790 3,200\ub9cc \uba85\uc774 \uc2dd\ud488 \uc54c\ub808\ub974\uae30\ub97c \uac00\uc9c0\uace0 \uc788\uc73c\uba70, \uc774 \uc911 560\ub9cc \uba85\uc740 18\uc138 \ubbf8\ub9cc \uc544\ub3d9\uc774\ub77c\uace0 \ucd94\uc815\ud569\ub2c8\ub2e4. \uc774\ub4e4 \uc544\ub3d9\uc758 \uc57d 40%\ub294 \ud55c \uac00\uc9c0 \uc774\uc0c1\uc758 \uc2dd\ud488\uc5d0 \uc54c\ub808\ub974\uae30\uac00 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \ubbf8\uad6d \uc54c\ub808\ub974\uae30, \ucc9c\uc2dd \ubc0f \uba74\uc5ed\ud559\ud68c(American College of Allergy, Asthma, and Immunology) \ub370\uc774\ud130\uc5d0 \ub530\ub974\uba74, \uc54c\ub808\ub974\uae30\ub294 \ubbf8\uad6d\uc5d0\uc11c \uc5ec\uc12f \ubc88\uc9f8\ub85c \ud754\ud55c \ub9cc\uc131 \uc9c8\ud658\uc73c\ub85c, \uc5f0\uac04 180\uc5b5 \ub2ec\ub7ec \uc774\uc0c1\uc758 \ube44\uc6a9\uc774 \ubc1c\uc0dd\ud558\uba70 \ub9e4\ub144 5\ucc9c\ub9cc \uba85 \uc774\uc0c1\uc774 \uc54c\ub808\ub974\uae30\ub85c \uace0\ud1b5\ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uc9c8\ubcd1\ud1b5\uc81c\uc608\ubc29\uc13c\ud130(CDC)\uc758 2021\ub144 10\uc6d4 \ub370\uc774\ud130\uc5d0 \ub530\ub974\uba74, \ubbf8\uad6d \uc131\uc778 4\uba85 \uc911 \uc57d 1\uba85(23.7%, \uc57d 5,850\ub9cc \uba85)\uc774 \uc758\uc0ac \uc9c4\ub2e8 \uad00\uc808\uc5fc\uc744 \uc553\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uce90\ub098\ub2e4 \uc815\ubd80\uc5d0 \ub530\ub974\uba74, 2020\ub144 9\uc6d4 \uae30\uc900 16\uc138 \uc774\uc0c1 \uce90\ub098\ub2e4\uc778 \uc57d 374,000\uba85(1.2%)\uc774 \ub958\ub9c8\ud2f0\uc2a4 \uad00\uc808\uc5fc \uc9c4\ub2e8\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n    \uc774\ub7ec\ud55c \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658\uc758 \uad11\ubc94\uc704\ud55c \uc720\ubcd1\ub960\uc740 \ud6a8\uacfc\uc801\uc778 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uc218\uc694\ub97c \ucc3d\ucd9c\ud558\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc5f0\uad6c \uac1c\ubc1c \ubc0f \uc81c\ud488 \uc2b9\uc778 \uc99d\uac00: \uc774 \uc9c0\uc5ed\uc5d0\uc11c \uae30\uc5c5\ub4e4\uc758 \uc5f0\uad6c \uac1c\ubc1c \ud65c\ub3d9 \uc99d\uac00\uc640 \uc81c\ud488 \uc2b9\uc778 \uc99d\uac00\ub294 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud560 \uac83\uc785\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, 2021\ub144 12\uc6d4 \ubbf8\uad6d \uc2dd\ud488\uc758\uc57d\uad6d(FDA)\uc740 \uc625\ud0c0\ud30c\ub9c8(Octapharma)\uc758 \ud050\ud0c0\ud034\uadf8(Cutaquig, \uba74\uc5ed\uae00\ub85c\ubd88\ub9b0, \ud53c\ud558 [\uc778\uac04]-hipp, 16.5% \uc6a9\uc561)\ub97c 2\uc138 \uc774\uc0c1 \uc18c\uc544 \uc6d0\ubc1c\uc131 \uccb4\uc561\uc131 \uba74\uc5ed\uacb0\ud54d(PI) \ud658\uc790 \uce58\ub8cc\uc81c\ub85c \uc0c8\ub85c\uc6b4 \uc801\uc751\uc99d\uc744 \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 5. \uacbd\uc7c1 \ud658\uacbd \ubc0f \uc8fc\uc694 \uae30\uc5c5<\/p>\n<p>\uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc18c\uc218\uc758 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc774 \uc874\uc7ac\ud558\ub294 \ud1b5\ud569\ub41c(consolidated) \uc2dc\uc7a5\uc785\ub2c8\ub2e4. \uc2dc\uc7a5 \uc810\uc720\uc728 \uce21\uba74\uc5d0\uc11c \ubcfc \ub54c, \uba87\uba87 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc774 \ud604\uc7ac \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uae30\uc5c5:<br \/>\n*   Baxter International Inc.<br \/>\n*   Takeda Pharmaceutical Company Limited<br \/>\n*   CSL Ltd<br \/>\n*   Biotest AG<br \/>\n*   Octapharma AG<br \/>\n*   Kedrion Biopharma Inc.<br \/>\n*   Bio Products Laboratory Limited<br \/>\n*   LFB group<br \/>\n*   Grifols S.A.<br \/>\n*   Lupin Pharmaceuticals<\/p>\n<p># 6. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2022\ub144 9\uc6d4: Lactiga Therapeutics\ub294 \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658 \ud658\uc790\ub97c \uc704\ud55c \uce58\ub8cc\uc81c \uac1c\ubc1c\uc744 \uc704\ud574 160\ub9cc \ub2ec\ub7ec\uc758 \uc2dc\ub4dc \ud22c\uc790 \uc720\uce58\uc5d0 \uc131\uacf5\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2022\ub144 4\uc6d4: Pharming Group N.V.\ub294 \ud65c\uc131\ud654\ub41c \ud3ec\uc2a4\ud3ec\uc774\ub178\uc2dc\ud2f0\ub4dc 3-\ud0a4\ub098\uc81c \ub378\ud0c0(PI3K\u03b4) \uc99d\ud6c4\uad70(\uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d) \uce58\ub8cc\ub97c \uc704\ud55c \ub808\ub2c8\uc62c\ub9ac\uc2ed(leniolisib)\uc758 \ud575\uc2ec 2\/3\uc0c1 \uc784\uc0c1 \uc2dc\ud5d8\uc5d0\uc11c \uae0d\uc815\uc801\uc778 \ub370\uc774\ud130\ub97c \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p># \uacb0\ub860<\/p>\n<p>\uc804\ubc18\uc801\uc73c\ub85c \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00\uc640 \uc720\uc804\uc790 \uce58\ub8cc\ub97c \ud3ec\ud568\ud55c \uae30\uc220 \ubc1c\uc804, \uadf8\ub9ac\uace0 \ubd81\ubbf8 \uc9c0\uc5ed\uc758 \uac15\ub825\ud55c \uc758\ub8cc \uc778\ud504\ub77c \ubc0f \ub192\uc740 \uc758\ub8cc\ube44 \uc9c0\ucd9c\uc5d0 \ud798\uc785\uc5b4 \uafb8\uc900\ud55c \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ub192\uc740 \uce58\ub8cc \ube44\uc6a9\uacfc \ubd80\uc791\uc6a9\uc740 \ub3c4\uc804 \uacfc\uc81c\ub85c \ub0a8\uc544\uc788\uc9c0\ub9cc, \ud65c\ubc1c\ud55c \uc5f0\uad6c \uac1c\ubc1c\uacfc \uae30\uc5c5\ub4e4\uc758 \ud22c\uc790 \ubc0f \uc81c\ud488 \uc2b9\uc778 \ud65c\ub3d9\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc9c0\uc18d\uc801\uc73c\ub85c \uacac\uc778\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>&#8220;\uae00\ub85c\ubc8c \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c \uc2dc\uc7a5 \ubcf4\uace0\uc11c&#8221;\ub294 \uc2e0\uccb4 \uba74\uc5ed \uccb4\uacc4\uc758 \uc77c\ubd80\uac00 \uacb0\ud54d\ub418\uac70\ub098 \uc815\uc0c1\uc801\uc73c\ub85c \uae30\ub2a5\ud558\uc9c0 \uc54a\ub294 \ub2e4\uc591\ud55c \uc9c8\ud658\uc744 \ud3ec\uad04\ud558\ub294 \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d\uc99d(Primary Immunodeficiency)\uc5d0 \ub300\ud55c \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc744 \uc2ec\uce35 \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc5f0\uad6c \uac00\uc815, \uc2dc\uc7a5 \uc815\uc758, \uc5f0\uad6c \ubc94\uc704 \ubc0f \ubc29\ubc95\ub860\uc744 \uba85\ud655\ud788 \uc81c\uc2dc\ud558\uba70, \uc2dc\uc7a5\uc758 \uc804\ubc18\uc801\uc778 \uac1c\uc694\ub97c \uc81c\uacf5\ud558\ub294 \uc694\uc57d(Executive Summary)\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc5ed\ud559(Market Dynamics) \ubd80\ubb38\uc5d0\uc11c\ub294 \uc2dc\uc7a5 \uac1c\uc694\uc640 \ud568\uaed8 \uc8fc\uc694 \ub3d9\uc778 \ubc0f \uc81c\uc57d \uc694\uc778\uc744 \uc0c1\uc138\ud788 \ub2e4\ub8f9\ub2c8\ub2e4. \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\uc778\uc73c\ub85c\ub294 \uba74\uc5ed\uacb0\ud54d \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00\uc640 \uc720\uc804\uc790 \uce58\ub8cc \ubd84\uc57c\uc758 \uae30\uc220 \ubc1c\uc804\uc774 \uaf3d\ud799\ub2c8\ub2e4. \ubc18\uba74, \ub192\uc740 \uce58\ub8cc \ube44\uc6a9\uacfc \uce58\ub8cc \uad00\ub828 \ubd80\uc791\uc6a9\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc81c\uc57d \uc694\uc778\uc73c\ub85c \ubd84\uc11d\ub429\ub2c8\ub2e4. \ub610\ud55c, \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d(\uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611, \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825, \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825, \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611, \uacbd\uc7c1 \uac15\ub3c4)\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uacbd\uc7c1 \ud658\uacbd\uc744 \ud3c9\uac00\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654\ub294 \uc9c8\ubcd1 \uc720\ud615\ubcc4, \uc81c\ud488 \uc720\ud615\ubcc4, \uc9c0\uc5ed\ubcc4\ub85c \uc774\ub8e8\uc5b4\uc9d1\ub2c8\ub2e4.<br \/>\n*   \uc9c8\ubcd1 \uc720\ud615\ubcc4: \ud56d\uccb4 \uacb0\ud54d(Antibody Deficiency), \uc138\ud3ec\uc131 \uba74\uc5ed\uacb0\ud54d(Cellular Immunodeficiency), \uc120\ucc9c\uc131 \uba74\uc5ed \uc9c8\ud658(Innate Immune Disorders) \ubc0f \uae30\ud0c0 \uc720\ud615\uc73c\ub85c \ubd84\ub958\ub429\ub2c8\ub2e4.<br \/>\n*   \uc81c\ud488 \uc720\ud615\ubcc4: \uba74\uc5ed\uae00\ub85c\ubd88\ub9b0 \ub300\uccb4 \uc694\ubc95(Immunoglobulin Replacement Therapy), \uc904\uae30\uc138\ud3ec\/\uace8\uc218 \uc774\uc2dd(Stem Cell\/Bone Marrow Transplantation), \ud56d\uc0dd\uc81c \uc694\ubc95(Antibiotic Therapy), \uc720\uc804\uc790 \uce58\ub8cc(Gene Therapy) \ubc0f \uae30\ud0c0 \uce58\ub8cc\ubc95\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778 \ubc0f \uae30\ud0c0 \uc720\ub7fd), \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud638\uc8fc, \ud55c\uad6d \ubc0f \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74(GCC, \ub0a8\uc544\ud504\ub9ac\uce74 \ubc0f \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74), \ub0a8\ubbf8(\ube0c\ub77c\uc9c8, \uc544\ub974\ud5e8\ud2f0\ub098 \ubc0f \uae30\ud0c0 \ub0a8\ubbf8) \ub4f1 \uc8fc\uc694 \uc9c0\uc5ed\uc5d0 \uac78\uccd0 17\uac1c\uad6d\uc758 \uc2dc\uc7a5 \uaddc\ubaa8\uc640 \ucd94\uc138\ub97c USD \ubc31\ub9cc \ub2e8\uc704\ub85c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd(Competitive Landscape) \uc139\uc158\uc5d0\uc11c\ub294 Baxter International Inc., Takeda Pharmaceutical Company Limited, CSL Ltd, Octapharma AG, Biotest AG, Kedrion Biopharma Inc., Bio Products Laboratory Limited, LFB group, Grifols S.A, Lupin Pharmaceuticals \ub4f1 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \uc0ac\uc5c5 \uac1c\uc694, \uc7ac\ubb34 \ud604\ud669, \uc81c\ud488 \ubc0f \uc804\ub7b5, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d \ub4f1\uc744 \ud3ec\ud568\ud55c \uc0c1\uc138\ud55c \uae30\uc5c5 \ud504\ub85c\ud544\uc744 \uc81c\uacf5\ud558\uc5ec \uc2dc\uc7a5 \ub0b4 \uacbd\uc7c1 \uad6c\ub3c4\ub97c \uc870\uba85\ud569\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \ub3d9\ud5a5\uc5d0 \ub300\ud55c \ubd84\uc11d\uc744 \uc81c\uc2dc\ud569\ub2c8\ub2e4.<\/p>\n<p>\ud575\uc2ec \uc9c8\ubb38 \ub2f5\ubcc0\uc5d0 \ub530\ub974\uba74, \uae00\ub85c\ubc8c \uc6d0\ubc1c\uc131 \uba74\uc5ed\uacb0\ud54d \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 6.1%\uc758 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec \uae30\uc5c5\uc73c\ub85c\ub294 Baxter International Inc., Takeda Pharmaceutical Company Limited, CSL Ltd, Octapharma AG, Biotest AG \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uac00\uc7a5 \ub192\uc740 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, 2025\ub144 \uae30\uc900\uc73c\ub85c\ub294 \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \ubd84\uc11d\ub429\ub2c8\ub2e4. \ubcf8 \ubcf4\uace0\uc11c\ub294 2019\ub144\ubd80\ud130 2024\ub144\uae4c\uc9c0\uc758 \uacfc\uac70 \uc2dc\uc7a5 \uaddc\ubaa8 \ub370\uc774\ud130\uc640 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc758 \uc608\uce21 \uc2dc\uc7a5 \uaddc\ubaa8\ub97c \ud3ec\ud568\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-55347","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/55347"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=55347"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/55347\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=55347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=55347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=55347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}